Untreated sleep apnea increases the risk of stroke and heart disease, yet many patients quit the standard CPAP mask treatment because it is uncomfortable. To solve this, researchers at the University of Gothenburg tested a drug called Sulthiame. In clinical trials, it reduced breathing pauses by up to 47%. The benefit is a potential "pill-based" alternative that stabilizes breathing and improves oxygen levels, helping those who cannot tolerate masks stay healthy and safe.
